Corneal Transplant Market Research Report - Forecast till 2030

Corneal Transplant Market Information: By Type (Penetrating Keratoplasty, Corneal Graft), Indication (Corneal Stromal Dystrophies, Fungal Corneal Ulcer, Bullous Keratopathy, Keratoconus, Keratitis), End User (Hospitals) - Forecast till 2030

ID: MRFR/MED/3107-HCR | 110 Pages | Published By Rahul Gotadki on March 2023         

Corneal Transplant Market Speak to Analyst Request a Free Sample

Corneal Transplant Market

The corneal transplant market is growing at a fast rate with the rise in the number of eyesight-related corneal problems globally

By Type Penetrating Keratoplasty Corneal Graft
By Indication Corneal Stromal Dystrophies Fungal Corneal Ulcer Bullous Keratopathy Keratoconus Keratitis
Key Players
Companies Profiled   CryoLife Inc. (U.S.)   Exactech Inc. (U.S.)   K√∂hler GmbH (U.S.)   Lifeline Scientific (U.S)   LifeCell Corporation (U.S.)   Medtronic (U.S.)   Organogenesis Inc. (U.S.)
Market Driving Forces   High prevalence of corneal eye disease   Rising number of corneal transplants
Request a Free Sample

Corneal Transplant Market Analysis

The corneal transplant market is expected to gain a market value of USD 792.54 million by 2030 at a CAGR of 11.2% over the forecast period of 2022-2030.

A corneal transplant is a technique for replacing a damaged or diseased cornea that may have developed due to an eye accident or an eye condition. The two most common transplant procedures worldwide are penetrating keratoplasty, which is full thickness cornea transplant, and endothelial keratoplasty, which is back layer cornea transplant. Vision blurring due to a sick cornea indicates the need for a corneal transplant.

Increases in the frequency of corneal eye illness, the number of patients, the number of corneal transplants performed globally, and consumer demand for less invasive surgical treatments are some key factors contributing to the market's expansion. The rising incidence of ocular conditions such as Fuchs dystrophy, keratoconus, and infectious keratitis are some major growth factors. According to National Keratoconus Foundation, approximately 15-20% of individuals with keratoconus require corneal transplant surgery. The market for corneal transplants is also growing as a result of increased awareness of corneal transplants' aesthetic advantages. The aging population is anticipated to boost market expansion. Additionally, improvements in the market's growth may be brought about by an increase in the benefits of minimally invasive treatment and an increase in investments.

Covid 19 Analysis

The COVID-19 pandemic harmed the market for corneal implants. Non-essential procedures were suspended during the pandemic to treat COVID-19 patients. For instance, corneal transplants decreased during the COVID-19 pandemic outbreak. Initially, alternative diagnostic procedures were attempted, but they were unsuccessful. Due to the unavailability of specific COVID-19 diagnostic tests, diagnostic kit manufacturers had profitable chances to market their COVID-19 diagnostic products. Utilizing this chance, many established companies and a few start-ups from different nations offered COVID-19 diagnostics kits into the local and international corneal transplant market. By taking advantage of the demand for COVID-19 diagnostic tests, these players gained an advantage over other diagnostics players, which enables them to sustain their revenue amid a crisis.

Market Dynamics


The growing prevalence of ophthalmic diseases owing to a lifestyle change is driving the corneal transplant market. Corneal blindness is a major problem affecting a large population globally and is quite common among geriatric populations. Eyesight disorders are common in people suffering from diabetes, obesity, malnutrition, and other lifestyle-related problems. Corneal transplantation has a high success rate of about 90 % and is getting highly popular. 

Advancements in medical technology are a positive factor for corneal transplant market growth. The acceptance rate of minimally invasive surgeries like corneal transplantation has grown considerably in recent times owing to increasing awareness. Moreover, the number of organ and tissue donations is also rising with increasing literacy rates in different regions of the world. Furthermore, a decrease in operating costs will further fuel the growth of the corneal transplant market.  


The high cost of optical devices and transplantation is the major factor hindering the growth of the corneal transplantations market. This factor along with less availability of donors of corneal tissue keeps the large population out of the medical reach. 

Technology Analysis

Corneal transplantation is a procedure of replacing damaged or diseased cornea with healthy donor tissue. It is a method of surgical treatment for several corneal problems which may arise due to eye injury or eye disease. This method is also known as keratoplasty or a corneal graft.

The cornea is a thin and clear outer layer of the eyeball that helps in focusing light rays onto the retina. It also protects the iris, pupil, and other internal parts. Corneal disorders and disease are prevalent worldwide as it is susceptible to damage. Corneal damage leads to blurred vision or even complete blindness sometimes. A doctor recommends corneal transplantation when it cannot be healed or repaired. 

The two major corneal transplantations are Penetrating keratoplasty (full-thickness cornea transplant) and endothelial keratoplasty (back layer cornea transplant). Descemet's stripping automated endothelial keratoplasty, or DSAEK, or DSEK is a relatively newer modification of endothelial keratoplasty that offers quicker recovery. 

Study Objectives

The specific objectives of corneal transplant market report on corneal transplantation are given below: 

  • To provide a complete overview of the corneal transplant market

  • To analyze and forecast the corneal transplant market in terms of value and volume.

  • To provide information about the impact of covid 19 on the market.

  • To identify the problems and prospects of the corneal transplant market.

  • To give details about the technological know-how of the process and products.

  • To provide an overview of the regional market and potentially growing market segments.

  • To identify the key players of the corneal transplantation industry.¬†

Segment Analysis 

Segmentation of the corneal transplant market, By type

  • Penetrating keratoplasty

  • Endothelial keratoplasty

  • Descemet stripping Automated Endothelial Keratoplasty (DSAEK)

  • Corneal graft

  • Corneal limbal stem cell transplant

  • Others¬†

The penetrating keratoplasty segment is the largest market segment owing to its ease of performance and higher success rate. It is a full-thickness corneal transplant where a circular portion of the cornea is cut out and replaced with donor tissue. This method helps in the full removal of damaged corneal tissue and improves optical clarity. Moreover, it doesn't hamper corneal anatomy and thereby improves cosmetic appearance.  

Segmentation of the corneal transplant market, By disease indication

  • Fungal keratitis

  • Fuchs‚Äô dystrophy

  • Keratoconus

  • other diseases

Fuchs' dystrophy is the dominating market segment owing to its higher prevalence rate. It is a common disorder having an occurrence rate of about 30 % for both males and females suffering from corneal problems. This problem occurs due to the destruction of endothelium cells in the cornea. The Cornea swells due to fluid buildup and leads to blurred vision. 

However, there has been a significant rise in the case of fungal keratitis which occurs due to improper care and cleaning of the eye.  

Segmentation of the corneal transplant market, By end-users

  • Hospitals

  • Eye clinics

  • Others¬†

Eye Clinics account for the largest market share. Eye clinics have specialized professionals to deal with eye patients. Moreover, the treatment is quicker in eye clinics than in hospitals.  

Regional Analysis

The different regional markets for the corneal transplant market are: 

  • America

    • North America

      • US

      • Canada

      • Mexico¬†

  • South America

    • Brazil

    • Argentina¬†

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Rest of Europe¬†

  • Asia-Pacific

    • China

    • India

    • Japan

    • Australia & New Zealand

    • Rest of Asia-Pacific¬†

  • Rest of the world ( RoW )

    • The Middle East¬†

Europe is the largest regional segment of the corneal transplant market. Well-developed medical infrastructure and research backup is creating a favorable environment for the growth of the corneal transplant market. There is a considerable emphasis on organ donation programs by Governments and NGOs in this region. Moreover, the high disposable income of the people in this region makes the demand stronger.

The American market is the second-largest market segment. There is a rising demand for corneal transplantation owing to the increasing prevalence of eye-related disorders. According to a study, an average of 40, 000 transplantations are performed daily in the USA. The rising geriatric population and prevalence of lifestyle disorders such as diabetes, hypertension, and obesity are creating a conducive environment for market growth here.

The Asia-Pacific segment is the fastest-growing market segment. Factors like Increasing awareness about transplantation and developing health infrastructure are boosting the market growth here. Moreover, the rise in disposable income of people is generating huge demand for corneal transplantation.

The Middle East and African segment are also expected to grow at a moderate rate. The increasing prevalence of the corneal disease is expected to generate huge demand there.  

Competitive Landscape 

The major global companies playing a key role in the corneal transplant market are :

  • CryoLife, Inc. (U.S.)

  • Exactech, Inc. (U.S.)

  • K√∂hler GmbH (U.S.)

  • Lifeline Scientific (U.S)

  • LifeCell Corporation (U.S.)

  • Medtronic (U.S.)

  • Organogenesis Inc. (U.S.)¬†

Recent Developments

  • In August 2022, Lions Eye Institute for Transplant and Research announced to acquire SightLife.

  • In November 2021, Ivantis, Inc.'s Hydrus Microstent for Surgical Glaucoma will be acquired by Alcon, strengthening its global ophthalmology portfolio.

  • In September 2020, in the United States, Dana-Farber and Mass Eye and Ear physicians worked together to repair damaged corneas using the patient's stem cells.

Intended Audience

This report will be beneficial for every stakeholder of the corneal transplant market such as :

  • Eye Hospitals

  • Eye Surgery Centers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors¬†

Report Overview

This report provides an in-depth analysis of the corneal transplant market in terms of current value and future forecast. It aims to provide detailed information about the problems and prospects of the given market. Moreover, the technological analysis section of the product will greatly help in getting better knowledge about the product and its market prospects. Furthermore, this report contains a detailed analysis of every segment of the given market for the current forecast period. This report has also highlighted the key players and the current developments in the corneal transplant market. 

Report Scope:

Report Attribute/Metric Details
  Market Size   2030: Significant Value
  CAGR   7.10% (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Indication, and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   CryoLife, Inc. (U.S.), Exactech, Inc. (U.S.), K√∂hler GmbH (U.S.), Lifeline Scientific (U.S), LifeCell Corporation (U.S.), Medtronic (U.S.), and Organogenesis Inc. (U.S.)
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • High prevalence of corneal eye disease
  • Rising number of corneal transplants

  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Corneal transplant market is projected to grow at an 7.10% CAGR between 2022- 2030.

    Europe is expected to dominate the corneal transplant market.

    Rising number of corneal transplants and increasing incidence of corneal eye disease are the key factors driving the corneal transplant market growth.

    High cost may limit the corneal transplant market growth.

    Key players profiled in the corneal transplant market include Organogenesis Inc. (U.S.), Medtronic (U.S.), LifeCell Corporation (U.S.), Lifeline Scientific (U.S), Köhler GmbH (U.S.), Exactech, Inc. (U.S.), and CryoLife, Inc. (U.S.).